Scarica l'app Stockscreener
8.02
3.22%
+0.25
Dopo l'orario di chiusura:
8.09
0.07
+0.87%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ARDX Giù?
Forum
Previsione
Ardelyx Inc Borsa (ARDX) Ultime notizie
Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Irritable Bowel Syndrome with Constipation at the 2024 Digestive Disease Week Conference
GlobeNewswire Inc.
Ardelyx (ARDX) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.
Rigel Pharmaceuticals (RIGL) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Zacks Investment Research
Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Zacks Investment Research
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
A Closer Look at 6 Analyst Recommendations For Ardelyx
Benzinga
Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire Inc.
Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire Inc.
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
GlobeNewswire Inc.
Where Ardelyx Stands With Analysts
Benzinga
Why AXT Shares Are Trading Higher By Around 36%; Here Are 20 Stocks Moving Premarket
Benzinga
Ardelyx Posts Q4 Loss, Joins MercadoLibre, Booking Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Benzinga
Ardelyx (ARDX) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks Investment Research
Ardelyx (ARDX) Reports Q4 Loss, Lags Revenue Estimates
Zacks Investment Research
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire Inc.
Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know
Zacks Investment Research
Suncor's (SU) Q4 Earnings Preview: Key Things to Consider
Zacks Investment Research
Lantheus (LNTH) to Report Q4 Earnings: What's in the Cards?
Zacks Investment Research
Marathon (MRO) Q4 Earnings on Deck: Here's How It Will Fare
Zacks Investment Research
Ardelyx (ARDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks Investment Research
Wall Street Analysts Believe Ardelyx (ARDX) Could Rally 34.84%: Here's is How to Trade
Zacks Investment Research
Ardelyx (ARDX) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks Investment Research
Ardelyx (ARDX) Upgraded to Buy: What Does It Mean for the Stock?
Zacks Investment Research
Is Ardelyx (ARDX) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research
Eli Lilly (LLY) Tops Q4 Earnings and Revenue Estimates
Zacks Investment Research
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
GlobeNewswire Inc.
Wedbush Maintains Outperform Rating for Ardelyx: Here's What You Need To Know
Benzinga
Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire Inc.
What Analysts Are Saying About Ardelyx Stock
Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Ardelyx to Provide Company Update on IBSRELA® and Host a KOL Discussion on the IBS-C Landscape on Monday, January 8
GlobeNewswire Inc.
Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire Inc.
Patient Demand Drives Ardelyx's Constipation Drug Success Amid IBS-C Treatment Gap, Says Analyst
Benzinga
Penny Stocks To Buy Now? 5 Under $5 To Watch This Week
PennyStocks
5 Hot Penny Stocks To Watch Today
PennyStocks
The Latest Analyst Ratings for Ardelyx
Benzinga
Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire Inc.
3 Top Penny Stocks To Watch Before Next Week
PennyStocks
Ardelyx to Participate at the Piper Sandler 35th Annual Healthcare Conference
GlobeNewswire Inc.
Penny Stocks To Buy? 4 Under $5 To Watch Right Now
PennyStocks
Ardelyx (ARDX) Up on Xphozah's Orphan Tag for Hyperphosphatemia
Zacks Investment Research
0.65%
0.65%
Capitalizzazione:
|
Volume (24 ore):